A combined proteomics and Mendelian randomization approach to investigate the effects of aspirin-targeted proteins on colorectal cancer

Authors Nounu A, Greenhough A, Heesom KJ, et al.
Citation Cancer Epidemiol Biomarkers Prev. 2020 Dec 14;cebp.1176.2020.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/33318029/
PMCID PMC8086774

Read this next

Combined effect of modifiable and non-modifiable risk factors for colorectal cancer risk in a pooled analysis of 11 population-based studies.